{
  "retracted": false,
  "timestamp": 1559260800000,
  "updates": [
    {
      "timestamp": 1590797580216,
      "identifier": {
        "doi": "10.1007/s13300-019-0638-y"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s13300-019-0630-6"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting"
}
